Serving more than 60 countries, Mayo Clinic Laboratories is creating a new standard for global diagnostic testing, offering international clients a vast test menu, access to Mayo Clinic experts, superior customer service, and more.
A clearer path through a difficult diagnosis - Insights
The fourth episode of “Life of a Specimen” video series explores the diagnosis enabled by antibody testing on Joy Carol’s cerebrospinal cord fluid and how her test result illuminated a path forward.
Grounded in gratitude, embracing treatment with hope - Insights
The fifth episode of “Life of a Specimen” video series highlights Joy Carol’s treatment journey after Mayo Clinic Laboratories antibody testing identified a paraneoplastic autoimmune disorder as the cause of her life-threatening symptoms.
A shared journey through breast cancer: Samantha Duke and Jane Hanson - Insights
When Samantha Duke discovered she had breast cancer, she didn’t have to look far for support. Her mother Jane walked a similar path 16 years earlier. Inspired both by her mom and the strong network of healthcare physicians and professionals...
Ceramide testing helps shape individualized heart health treatment plan: Mark Kocak - Insights
An avid runner and fitness buff, Mark Kocak didn’t think he needed medication for his high cholesterol and hypertension. After coming to Mayo Clinic for ceramide testing, Mark knew exercise alone would not be enough to him on a path toward...
Converging on a major milestone in digital pathology - Insights
Successful implementation of a new slide scanning and analysis platform across five laboratories represents a significant step forward in Mayo Clinic’s digital pathology program — an initiative that combines advanced technology with human...
Focused lung panel informs the use of targeted cancer therapies - Insights
Ying-Chun Lo, M.D., Ph.D., explains how Mayo Clinic Laboratories' updated lung panel can better guide clinical decision-making, particularly about targeted lung cancer therapies.
Pathways Case Studies: June 2022 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for June include the following sub-specialties: Dermatopathology, Gastroenterology...
Mayo Clinic Laboratories’ comprehensive menu of genetic cardiovascular testing provides results that support gene-based strategies to manage inherited cardiovascular disease.
Cytomegalovirus, or CMV, is a common cause of disease in the transplant population. In some patients who are diagnosed with CMV and are on antiviral treatment for infections, the virus may develop resistance to the drugs. This “Hot Topic”...
CPT codes and LOINC update: May 2023 - Insights
This page includes updates posted to Mayo Clinic Labs during the month of May.
April 2023 - Ophthalmic Pathology - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Ophthalmic Pathology.
Autoimmune testing education - Insights
Mayo Clinic Laboratories is leading an evolution in autoimmune neurology diagnosis. Powered by expertise from our research labs, clinical labs, and Autoimmune Neurology Clinic, we have developed panels customized to address specific...
Then and now: Upholding Mayo Clinic's core values - Insights
Part two of the 50th Anniversary series highlights how Mayo Clinic Laboratories has remained focused on our core values through support of Mayo Clinic’s three shields – integrated clinical practice, research, and education.
Lisa Brown, quality specialist for Mayo Clinic Laboratories customer service, explains working "behind the scenes" when a client calls Mayo Clinic Laboratories with an inquiry, that call is typically picked up within 20 seconds by an agent...
Calprotectin and Inflammatory Bowel Disease - Insights
The differential diagnosis for inflammatory bowel disease (IBD) includes irritable bowel syndrome (IBS). While the clinical presentation is similar, IBD is an inflammatory disease, while IBS is a noninflammatory disease. View this "Hot...
Genetic Testing for Inherited Cardiovascular Disorders - Insights
In this month's "Hot Topic," Linnea Baudhuin, Ph.D., discusses Mayo Clinic Laboratories’ up-to-date gene panel tests for cardiomyopathies and arrhythmias, connective tissue and vascular fragility disorders, dyslipidemias, and congenital...
Laboratory Utilization Management: Tick-Borne Disease Testing - Insights
In this month's "Hot Topic," Elitza Theel, Ph.D., will be discussing laboratory utilization management, specifically for diagnostic testing for tick-borne diseases.
MayoComplete Next-Generation Sequencing: Oncology Subpanels - Insights
In this month's "Hot Topic," Kevin Halling, M.D., Ph.D., discusses new next generation sequencing testing for various tumor types and the rationale for the enhancements that were made; reviews gene additions that are now available in each...
After a long wait, the U.S. Food and Drug Administration has finally approved the Elecsys Troponin T Gen 5 STAT blood test. Recently, the Beckman hscTnI assay was also approved. These high-sensitivity troponin assays will benefit emergency...
Advancing Multiple Myeloma Diagnosis - Insights
The standard laboratory test to diagnose multiple myeloma dates back to the Eisenhower administration. Research at Mayo Clinic spearheaded by David Murray, M.D., Ph.D. (PATH ’10), and fueled by his experience as an industrial chemist has...
How an ex-NFL Linebacker Overcame His Greatest Opponent, Amyloidosis - Insights
Matt Millen, ex-pro NFL player, who played on four Super Bowl-winning teams underwent a nearly six-year medical journey in search for answers. Finally, he was diagnosed with amyloidosis using a new testing methodology at Mayo Clinic.
Beyond the Test Result: Greg Widseth - Insights
Greg Widseth was suddenly hit by a rare disease that prompted his immune system to attack his brain cells, resulting in as many as 60 seizures a day. Special blood and spinal fluid tests developed by Mayo Medical Laboratories confirmed that...
Syndromic Testing for Infectious Diseases: Respiratory Infections - Insights
In this month's "Hot Topic," Matthew Binnicker, Ph.D., discusses the use of multiplex panels for the diagnosis of respiratory infections and focuses on the clinical utility of these tests in the setting of upper respiratory tract...
MSA Patient Holds Steady Following Small Group Study of Stem Cell Therapy - Insights
Steve Day experiences balance issues, sleeping problems, and irregular blood pressure stem from a rare, unusual neurodegenerative disease—multiple system atrophy. Read his story.
The Collective Wisdom of Biobanks - Insights
Since ancient times, physicians have analyzed patient specimens to diagnose illness. Now, our samples can do far more than diagnose. They can help researchers find treatments for the unmet needs of patients.
Our staff, our stories: Andrew "Roo" Yori - Insights
Andrew “Roo” Yori’s persistence and athletic gifts allowed him to achieve his dream of becoming an American Ninja Warrior in 2016.
Amid COVID-19 upheaval, DLMP staff steps up - Insights
When COVID-19 hit, staff in Laboratory Medicine and Pathology at Mayo Clinic rose to the challenge with perseverance, flexibility, and resilience.
Ingenuity, collaboration, and expertise create a game-changing COVID-19 test swab - Insights
A massive effort culminated in Mayo Clinic designing, testing and mass-manufacturing a 3D-printed mid-turbinate swab for COVID-19 testing.
A web of care, close to home: Support on the cancer journey - Insights
Dr. Dollahite received world-class cancer treatment from a web of health care organizations, including Mayo Clinic in Rochester, Minnesota. Yet she never left New York; most of her treatment occurred in Ithaca. What made that possible was...
Epic journey yields unique offering - Insights
The quest to create a test pinpointing the source of the rare, testicular cancer-associated illness successfully concluded in the summer of 2021.
Diagnostic ecosystem boosts access to timely Alzheimer's disease testing - Insights
Mayo Clinic Laboratories has developed a cutting-edge suite of Alzheimer's disease testing. The newest assays use blood samples, avoiding the need for lumbar punctures to obtain cerebrospinal fluid. The testing suite exemplifies Mayo Clinic...
Gastroenterology Testing - Mayo Clinic Laboratories
All in One Place. From screening to therapeutic management, we offer a comprehensive,one-stop solution for gastroenterlogy test ordering.
Learn more about Mayo Clinic Laboratories testing for pregnancy loss, which can help determine causes and risk of recurrence for future pregnancies.
Epansive clinical test menu, including more than 3,500 CAP- and CLIA-accredited tests. In addition to offering the world’s most sophisticated specialty test menu, we provide access to research-grade tests, pathology services, and sponsored...
Accurate Kidney Stone Analysis - Insights
In this “Hot Topic,” Paul Jannetto, Ph.D., highlights Mayo Clinic Laboratories’ AI-augmented kidney stone test and discusses the proper procedures for collecting and processing kidney stones to provide accurate, cost-effective analysis of...
Autoimmune Neurology Testing - Mayo Clinic Laboratories
Recognized as a world leader in the diagnosis and treatment of autoimmune neurologic disorders, Mayo Clinic mounts unmatched resources for developing new diagnostic biomarkers and unique laboratory tests.
Learn about our menu of MayoComplete testing including a 515-gene panel and multiple disease-specific panels, which span the cancer spectrum.
Mayo Clinic Laboratories isn’t just a reference lab. We’re also the diagnostic lab for a hospital, just like your lab. So we know the many benefits of keeping tests as close to patients as possible.
A collaboration with Mayo Clinic BioPharma Diagnostics includes access to the neurologic disease testing capabilities of Mayo Clinic Laboratories. Our highly specialized neurology testing menu features more than 400 neurologist-backed...
Mayo Clinic Laboratories: Quality testing from start to finish - Insights
Guided by a patient-centric philosophy, Mayo Clinic Laboratories has a unique internal structure of quality specialists, coordinators, and engineers who constantly evaluate and improve laboratory operations. This structure supports a host...
The evolution of specimen accessioning and delivery - Insights
The last installment of our 50th Anniversary series explores how Mayo Clinic Laboratories pioneered best practices in the area of specimen accessioning and delivery.
A novel testing approach for newly identified VEXAS syndrome - Insights
VEXAS syndrome is a severe autoinflammatory disease that results in a spectrum of rheumatologic and hematologic conditions. The underlying cause of newly identified VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome —...
What started as a persistent headache for Spencer Lodin soon devolved into slowed speech, seizures, and hallucinations, symptoms which stumped ER doctors into thinking he had meningitis or was suffering from psychosis. Finally, specialized...
Synthesizing cardiovascular genetic test results into a unified diagnosis for the patient - Insights
For over two decades, Mayo Clinic has been at the forefront of cardiovascular (CV) genetic testing. The current test menu features 24 different panels that span over 300 genes linked to inherited cardiovascular disorders, many of which are...
Unveiling a novel hemoglobinopathy classification - Insights
In a recent discovery by Mayo Clinic Laboratories, a novel hemoglobinopathy category was identified and termed epsilon gamma thalassemia. The first instance of the disorder was found in 2017 when an obstetric patient underwent a routine...
Reclaiming strength and independence after rare cancer diagnosis: Alexa Lofaro - Insights
It’s been more than three years since a team of specialists and genetic testing by Mayo Clinic Laboratories helped pinpoint the cause of Alexa Lofaro’s failing health. And today, she says she continues to feel “so much better” than she did...
Regaining quality of life after a decade lost to misdiagnosis: Kelly Dubois - Insights
Misdiagnosed with acromegaly, a disease marked by too much growth hormone, and plagued by a host of mysterious health problems from unnecessary medications, Kelly DuBois finally found answers after pharmacogenomic testing from Mayo Clinic...
Enhanced technology safeguards patient specimens - Insights
Mayo Clinic's use of enhanced radio-frequency identification technology to track specimens from the clinical setting to the lab reduces the risk of errors and protects valuable — sometime irreplaceable — patient samples.
Neurofilament light chain test helps in diagnosis, treatment, and prognosis of ALS and MS - Insights
By using a test that measures neurofilament light chain (Nfl) proteins in blood, clinicians can better diagnose devastating diseases like ALS and MS, help predict disease progression, and better assess efficacy of existing drugs and trial...